Hidehiro Itonaga

3.0k total citations
65 papers, 371 citations indexed

About

Hidehiro Itonaga is a scholar working on Hematology, Immunology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Hidehiro Itonaga has authored 65 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 25 papers in Immunology and 12 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Hidehiro Itonaga's work include Acute Myeloid Leukemia Research (27 papers), Hematopoietic Stem Cell Transplantation (22 papers) and T-cell and Retrovirus Studies (16 papers). Hidehiro Itonaga is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Hematopoietic Stem Cell Transplantation (22 papers) and T-cell and Retrovirus Studies (16 papers). Hidehiro Itonaga collaborates with scholars based in Japan, United States and United Kingdom. Hidehiro Itonaga's co-authors include Yasushi Miyazaki, Tomoko Hata, Yoshitaka Imaizumi, Yasushi Sawayama, Koji Ando, Shinichiro Yoshida, Jun Taguchi, Yukiyoshi Moriuchi, Shinya Sato and Daisuke Imanishi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hidehiro Itonaga

57 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidehiro Itonaga Japan 11 177 158 93 70 63 65 371
Takuro Kuriyama Japan 10 150 0.8× 180 1.1× 49 0.5× 45 0.6× 59 0.9× 49 396
Abbas Shirdel Iran 12 71 0.4× 337 2.1× 197 2.1× 209 3.0× 36 0.6× 34 516
Luise Hartmann Germany 10 94 0.5× 46 0.3× 43 0.5× 58 0.8× 35 0.6× 20 254
Z. N. Berneman Belgium 11 70 0.4× 198 1.3× 116 1.2× 117 1.7× 35 0.6× 28 509
Masaharu Miyahara Japan 11 76 0.4× 173 1.1× 86 0.9× 62 0.9× 26 0.4× 32 321
M. Mine Japan 9 51 0.3× 108 0.7× 69 0.7× 61 0.9× 18 0.3× 18 317
George Bourikas Greece 12 201 1.1× 562 3.6× 246 2.6× 261 3.7× 143 2.3× 21 776
M Maruyama Japan 5 254 1.4× 177 1.1× 49 0.5× 35 0.5× 71 1.1× 7 411
Philippe Agapé France 10 276 1.6× 63 0.4× 13 0.1× 16 0.2× 130 2.1× 20 378
Shogo Takeuchi Japan 11 42 0.2× 189 1.2× 87 0.9× 67 1.0× 10 0.2× 20 343

Countries citing papers authored by Hidehiro Itonaga

Since Specialization
Citations

This map shows the geographic impact of Hidehiro Itonaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiro Itonaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiro Itonaga more than expected).

Fields of papers citing papers by Hidehiro Itonaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidehiro Itonaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiro Itonaga. The network helps show where Hidehiro Itonaga may publish in the future.

Co-authorship network of co-authors of Hidehiro Itonaga

This figure shows the co-authorship network connecting the top 25 collaborators of Hidehiro Itonaga. A scholar is included among the top collaborators of Hidehiro Itonaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidehiro Itonaga. Hidehiro Itonaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kurosawa, Shuhei, Yoshimitsu Shimomura, Ken Ishiyama, et al.. (2024). Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study. Bone Marrow Transplantation. 59(6). 742–750. 1 indexed citations
4.
Kato, Takeharu, Kenichi Yokota, Hikaru Sakamoto, et al.. (2024). Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy. International Journal of Hematology. 120(6). 694–704.
5.
Itonaga, Hidehiro, Hideyuki Nakazawa, Tetsuya Nishida, et al.. (2024). Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT. Transplantation and Cellular Therapy. 31(1). 18.e1–18.e12. 1 indexed citations
6.
7.
Konuma, Takaaki, Hidehiro Itonaga, Ken Ishiyama, et al.. (2023). Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?. Bone Marrow Transplantation. 58(8). 893–906. 2 indexed citations
8.
Koh, Hideo, Takaaki Konuma, Yoshimitsu Shimomura, et al.. (2023). HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome. Transplantation and Cellular Therapy. 30(3). 316.e1–316.e12. 1 indexed citations
9.
Otsubo, Ryota, et al.. (2022). Severe thrombocytopenia and anemia as an initial presentation of breast cancer: A case report. SHILAP Revista de lepidopterología. 10(12). e6762–e6762. 1 indexed citations
10.
Kurosawa, Shuhei, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.. (2022). Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis. Transplantation and Cellular Therapy. 28(6). 323.e1–323.e9. 6 indexed citations
11.
Itonaga, Hidehiro, Hikaru Sakamoto, Takeharu Kato, et al.. (2022). Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki Transplant Group Experience. Transplant Immunology. 75. 101707–101707. 2 indexed citations
12.
Chen, Chuan, Na Man, Fan Liu, et al.. (2022). Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer. Cancer Research. 82(11). 2047–2056. 7 indexed citations
13.
Shimomura, Yoshimitsu, Masahiko Hara, Takaaki Konuma, et al.. (2021). Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. Bone Marrow Transplantation. 56(10). 2510–2517. 9 indexed citations
14.
Kurosawa, Shuhei, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.. (2021). Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis. Bone Marrow Transplantation. 56(12). 3008–3015. 5 indexed citations
15.
Sakamoto, Hikaru, Hidehiro Itonaga, Jun Taguchi, et al.. (2019). Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience. Leukemia Research Reports. 11. 27–30. 3 indexed citations
16.
Kato, Takeharu, Hidehiro Itonaga, Jun Taguchi, et al.. (2019). Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement. Leukemia Research Reports. 11. 31–33. 4 indexed citations
17.
Itonaga, Hidehiro, Rika Kihara, Yasunobu Nagata, et al.. (2018). Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia. Leukemia Research. 65. 34–41. 5 indexed citations
18.
Itonaga, Hidehiro, Shinya Sato, Koji Ando, et al.. (2014). Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B. Leukemia. 28(7). 1459–1466. 21 indexed citations
19.
Itonaga, Hidehiro, Jun Taguchi, Takuya Fukushima, et al.. (2013). Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group. Biology of Blood and Marrow Transplantation. 19(4). 607–615. 18 indexed citations
20.
Fukushima, Takuya, Jun Taguchi, Yukiyoshi Moriuchi, et al.. (2011). Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: The Nagasaki Transplant Group experience. International Journal of Hematology. 94(4). 390–394. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuro Kuriyama Breakdown of academic impact, for papers by Abbas Shirdel Breakdown of academic impact, for papers by Luise Hartmann Breakdown of academic impact, for papers by Z. N. Berneman Breakdown of academic impact, for papers by Masaharu Miyahara Breakdown of academic impact, for papers by M. Mine Breakdown of academic impact, for papers by George Bourikas Breakdown of academic impact, for papers by M Maruyama Breakdown of academic impact, for papers by Philippe Agapé Breakdown of academic impact, for papers by Shogo Takeuchi
Rankless by CCL
2026